DEARBORN PARTNERS LLC

Position in ASND — Ascendis Pharma A/S

CIK 1206792 Chicago, IL

Position in ASND

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$346,736

+$49,387 QoQ

Shares Held

1,300

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#238

of 307 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DEARBORN PARTNERS LLC holds $630,532 across 3 Biotechnology names. ASND ranks #1 (55.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S This page	1,300	$346,736
2	NTLA	Intellia Therapeutics, Inc.	15,825	$267,758
3	IGC	IGC Pharma, Inc.	59,401	$16,038

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$346,736	1,300	0.0%	Shares	Sole	2026-08-17
2026-03-31	$297,349	1,300	0.0%	Shares	Sole	2026-05-12
2025-12-31	$277,212	1,300	0.0%	Shares	Sole	2026-02-11
2025-09-30	$258,453	1,300	0.0%	Shares	Sole	2025-11-10
2025-06-30	$224,380	1,300	0.0%	Shares	Sole	2025-08-14
2025-03-31	$202,618	1,300	—	Shares	Sole	2025-05-08
No filing history on record for this holder in this stock.